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Abstract (150 words) 
 
Menstrual disorders affect up to 30% of women of reproductive age and can 
have a significant impact on their quality of life. Hysteroscopy is frequently used 
to assess and treat endometrial pathology, which can cause abnormal uterine 
bleeding. There is growing evidence that hysteroscopy is an essential tool in 
outpatient management of patients. This chapter will deal with the evidence 
surrounding the role of hysteroscopy in a range of menstrual disorders.  
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Key words: Menstrual disorders; abnormal uterine bleeding; hysteroscopy; 
office; outpatient 
 
INTRODUCTION 
 
Background 
 
Hysteroscopy is the corner stone of modern day outpatient endoscopic 
treatments in gynecology. The first successful diagnostic and operative 
hysteroscopy was performed by DC Pantaleoni of Ireland, in 1869[1].  He utilized 
a modified cystoscope and reflected candlelight to examine and treat a polyp in a 
patient with post-menopausal bleeding (PMB). This paved the way forward for 
urologists and gynecologists to develop and achieve advancements in endoscopic 
procedures. Charles David in 1907 was the first to describe a lens system that 
would allow uterine cavity visualization[2]. Nevertheless, it wasn’t until 1943 
when, the combination of a cold light source developed by Forestiere[3] and a 
rod lens system developed by Professor Hopkins[4], revolutionized uterine 
cavity assessment and formed the basis of modern day out patient and in patient 
gynecologic endoscopy.    
Initially, hysteroscopy was developed as an inpatient procedure, which was done 
under general anesthetic. Advances in technology and in particular 
miniaturization of optics, has increasingly allowed both diagnostic and minor 
hysteroscopic surgical procedures to be performed in the outpatient setting [5–
8].  Outpatient hysteroscopy has been shown to be safe and acceptable to 
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women. Research has shown that the outpatient approach is more cost-effective 
and patients value the convenience of an immediate diagnosis [9,10].  This 
allows women to be counseled about their treatment options thus avoiding 
lengthy follow-up appointments.  Moreover, in some cases treatment can be 
started immediately in what is known as a ‘one-stop’ service.  Hence, office 
hysteroscopy is a well-accepted, convenient, cost-effective and rapid access ‘see 
and treat’ solution for several menstrual disorders [9–11].  
 
Menstrual disorders  
 
Menstrual disorders are problems that affect the normal menstrual cycle and 
commonly present as abnormal uterine bleeding (AUB) (Figure 1). These are 
fairly common amongst women of childbearing age with a reported incidence of 
about 9-14% and can have a major impact on the quality of life, of women of all 
ages [12]. 
 
<<Figure 1 here >> 
 
Whilst, these irregularities can present as disorders of menstrual flow, timing 
and duration, there are several organic and non-organic causes for this 
disruption. NICE describes the term dysfunctional uterine bleeding (DUB) as 
abnormal uterine bleeding (AUB) in the absence of organic disease [13]. 
In 2011, the International Federation of Gynecology and Obstetrics (FIGO) 
approved the PALM-COEIN classification as a FIGO classification system for the 
purpose of standardizing nomenclature for the causes of abnormal uterine 
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bleeding (Figure 2)[14]. This new classification was introduced to facilitate 
clinicians, researchers and patients in their interaction, communication, and 
reporting to provide clinically effective care.  
It is known that abnormal uterine bleeding can affect the quality of life of the 
individual concerned and can also represent an early warning sign of uterine 
malignancy, especially if occurring once menopause ensues. In these cases, 
careful clinical evaluation and assessment for treatment is merited. 
Hysteroscopy allows rapid assessment and treatment of conditions that cause 
abnormal uterine bleeding.     
 
<<Figure 2 here>> 
 
This chapter provides an overview of existing evidence and good practice in 
relation to the role of hysteroscopy in the diagnosis of menstrual disorders 
presenting as AUB in non-pregnant women. 
 
Approach to clinical evaluation in menstrual disorders 
 
Women with menstrual disorders may present with a wide range of variable 
symptoms with different etiologies. It is estimated that a quarter of women are 
referred to gynecology clinics with AUB [15].  In women below the age of 40 
years endometrial cancer is rare, however, it’s incidence rises steeply beyond 
ages 45 and 50+ years. Up to 10% of women with post menopausal bleeding 
(PMB) will have endometrial cancer [16]. Therefore, it is pertinent to adopt a 
structured approach to clinical evaluation before recommending diagnostic 
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imaging or treatment options.  A suggested approach is summarized in Table 1 
below.  
 
History Menstrual history:  
• Age group: Pre-pubertal, Reproductive, Post-menopausal  
• Last menstrual bleeding  
• Cycle intervals, quantity and duration of flow 
• Pre-menstrual symptoms 
• Post-coital bleeding 
• Inter-menstrual bleeding 
• Cervical smear  
• Trauma or foreign body 
• Sexually transmitted infections 
Associated symptoms:  
• Pain (dysmenorrhea, dyspareunia) 
• Vaginal discharge 
• Fever 
• Symptoms of fatigue 
• Changes in bowel and bladder function 
• Impact on quality of life 
Medical History:  
• Personal or family history of hematological disorders: 
coagulopathy, leukemia, von Willebrand disease, platelet 
disorders 
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• Changes in body weight, loss of appetite 
• Medication: Anti-coagulants, tamoxifen, anti-depressants, 
corticosteroids, thyroxine, contraceptives, hormone 
replacement therapy 
• Hyperestrogenic state: Diabetes, Polycystic ovarian 
syndrome  
• Liver disease, Thyroid dysfunction, Renal disease, Pituitary 
dysfunction 
• Smoking 
• Family history of gynecological malignancy 
Examination General Physical examination: 
• Pallor 
• Signs of systemic illness (Thyroid disease, liver disease, 
bleeding disorders) 
• BMI 
• Abdominal mass 
• Signs of hyperandrogenism: acne, hirsutism, male pattern 
baldness 
 Gynecological examination: 
• Assess perineum for any signs of atrophy, ulceration, 
infection, mass or lesion 
• Speculum examination: Rule out cervical pathology, pap 
smear and swabs for infection screening (Chlamydia and 
Gonorrohea nucleic acid amplification test) if indicated  
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• Bi-manual examination: Assess uterine size, mobility, 
consistency and assess for adnexal masses 
• Per-rectal examination: If suspicion of non-genital bleeding 
or malignancy involving parametrium or rectum. 
 
Table 1: Clinical evaluation in AUB  
 
A thorough history and examination provides insight in to the possible causes of 
AUB.  From this point on it is necessary to ascertain whether the suspected cause 
warrants immediate evaluation i.e. within two weeks or a more routine 
approach with evaluation in six weeks or more.  In cases where a high risk of 
malignancy is possible (PCOS, diabetes, tamoxifen, unopposed estrogen therapy, 
palpable abdominal mass, cervical or vulvo-vaginal mass on examination or post-
menopausal bleeding, non-cyclical bleeding in women on HRT) immediate 
referral to a specialist clinic for further evaluation is warranted.  Whereas cases 
where the bleeding may be secondary to more benign causes local routine 
referral pathways should be followed. 
 
Approach to diagnostics in menstrual disorders  
 
Historically, various diagnostic approaches have been suggested for preliminary 
investigation of menstrual disorders. Basic blood testing such as a full blood 
count allows evaluation of degree of anemia. Other tests; such as coagulation 
screening, renal function tests, prolactin, androgen levels and thyroid function 
tests etc are undertaken based on history-defined suspicion of disease.  
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The most commonly used investigation method in gynecological imaging is the 
pelvic transvaginal ultrasound (TVUS); this combined with endometrial biopsy 
and/or office hysteroscopy provides an invaluable diagnostic combination for 
assessment of AUB. Other imaging methods that have been suggested are saline 
infusion sonography (SIS) and special modalities such as CT and MRI (used when 
malignancy is suspected).  These methods are complementary assessment tools.  
It is also important to note that dilatation and curettage (D&C) is now only used 
in exceptional circumstances, as it requires general anesthesia, and has been 
largely replaced by outpatient endometrial biopsy.    
 
Pelvic transvaginal ultrasound (TVUS)   
 
With the use of TVUS, it is possible to visualize and assess the uterine cavity and 
the adjacent adnexa, when planning further treatment options.  This provides 
valuable information such as endometrial thickness (ET) and the presence or 
absence of structural abnormalities such as polyps or fibroids. TVUS is also 
minimally invasive and widely acceptable to women and helps triage women 
requiring further treatment. The sensitivity and specificity of TVUS for detection 
of fibroids and polyps alongside ET is 80% and 69% respectively [17].   
Therefore, to prevent endometrial lesions being missed, it is increasingly being 
suggested that hysteroscopy or SIS is recommended to further evaluate the 
endometrium[18].  In pre-menopausal women ET is best assessed on day four to 
six of the menstrual cycle as this is the time when the endometrium should be at 
its thinnest. If uterine cavity pathology is suspected then further investigation is 
merited. Furthermore, in cases where medical treatment has been unsuccessful 
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in premenopausal women hysteroscopy should be performed as there maybe 
underlying pathology, which may not be visible on TVUS.   
In post-menopausal women with PMB endometrial cancer is a major concern. 
Measuring ET on TVUS is valuable in triaging women who are at greater risk of 
endometrial cancer. A suggested threshold of < or = 4mm for ET with a regular 
endometrial lining and no fluid within the cavity reduces the possibility of 
malignancy to <1% in postmenopausal women [19,20]. An ET measuring >4mm 
warrants endometrial sampling as the risk of malignancy is higher [19,20].  TVUS 
thus allows adequate sensitivity for this threshold with a false-negative rate of 
0.25-0.50% and without excessive false-positive rates [21].  If clinical suspicion 
of malignancy persists, especially in symptomatic or high risk cases, then it is 
advisable to perform hysteroscopic evaluation as some endometrial pathology 
may be missed. The risk factors for endometrial cancer are obesity, diabetes, 
nulliparity, history of PCOS, and family history of hereditary non-polyposis 
colorectal cancer. 
 
Saline infusion sonography 
 
Compared to TVUS, saline infusion sonography (SIS) provides more information 
regarding intra-cavity uterine pathology, especially in cases where AUB persists 
despite a normal endometrial measurement on TVUS.  This applies to women of 
all ages with AUB.   Studies suggest that SIS has similar sensitivity and specificity 
for some endometrial lesions when compared to hysteroscopy.21 However, 
hysteroscopy can allow simultaneous treatment in the form of removal of the 
endometrial lesions such as polyps and small submucous fibroids.  Table 2 
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provides a summary of the sensitivity and specificity information of SIS for 
endometrial pathology as reported in a recent systematic review and meta-
analysis [22]. 
 
Technique Pathology Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Evidence Source 
SIS Endometrial Polyps 0.82 (0.76-0.86) 0.96 (0.95-0.98) Seshadri et al 2014 
(Systematic review 
and meta-analysis) 
Submucous fibroids 0.82 (0.69-0.92) 1.00 (0.98-1.00) 
Intrauterine adhesions 0.82 (0.65-0.93) 0.99 (0.98-1.00) 
All intrauterine pathology 0.88 (0.85-0.90) 0.94 (0.93-0.96) 
 
Table 2: Sensitivity and specificity of Saline infusion sonography for endometrial 
pathology 
 
Hysteroscopy 
 
Hysteroscopic equipment and associated technologies have rapidly advanced in 
recent years increasing the feasibility and range of hysteroscopic and surgical 
techniques for the treatment of women with AUB.  In particular the 
miniaturization of hysteroscopic equipment has facilitated one of the biggest 
recent changes in hysteroscopic practice, which is the establishment of 
outpatient diagnostic and therapeutic services.  The development of the 
miniature ancillary mechanical and electrosurgical equipment has allowed 
intrauterine pathologies such as polyps and small submucous fibroids to be 
removed in the outpatient setting.   During the visit the patient can also be fitted 
with a levonorgestrol-releasing intrauterine system (LNG-IUS) to treat HMB.  
This has led to contemporary models of care for women moving to ‘one-stop’ 
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ambulatory clinics, rather than traditional models which involve multiple 
hospital visits to review results.     
The ‘one-stop’ ambulatory hysteroscopy clinics have potential benefits for 
clinicians, patients and health services. Outpatient hysteroscopy has the 
advantage of providing a real time diagnosis that avoids anxiety, inconvenience 
and costs associated with follow-up appointments.  Different treatment options 
can be discussed and in some cases they can be initiated, avoiding morbidity 
associated with delays in initiating treatment.   The use of expensive theatre 
resources and inpatient hospital beds are substantially reduced, increasing 
service capacity [9,11].  
The adoption of ‘one-stop’ hysteroscopy clinics is further supported by a recent 
cost-effectiveness analysis examining the use of TVS, endometrial biopsy and SIS 
for the investigation of heavy menstrual bleeding.  The results of the study 
showed that outpatient hysteroscopy or outpatient hysteroscopy with 
endometrial biopsy were the most cost-effective options [9]. Several studies 
have reported on the diagnostic accuracy of hysteroscopy the results of a recent 
meta-analysis are shown in Table 3 [23]. 
 
Technique Pathology Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Evidence Source 
Hysteroscopy Endometrial Polyps 95.4% (87.4-98.4) 96.4% (93.7-98.0) Gkrozou et al 2014 
(Meta-analysis) 
 
Submucous fibroids 97.0% (89.8-99.2) 98.9% (93.3-99.8) 
Endometrial Cancer 82.6% (66.9-91.8) 99.7% (98.1-99.9) 
Endometrial hyperplasia 75.2% (55.4-88.1) 91.5% (85.7-95.0) 
 
Table 3: Sensitivity and specificity of hysteroscopy for endometrial pathology 
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Post menopausal bleeding 
 
Most guidelines suggest that TVUS is used as the first line investigation for 
women presenting with PMB[24,25].  When the endometrium is smooth and the 
thickness is ≤4mm with no free fluid in the endometrial cavity the incidence of 
malignancy is <1% and in this situation no further investigation is required. 
Otherwise it is recommended that further investigation in the form of an 
endometrial biopsy is performed [19,20]. 
When the TVUS shows endometrial irregularities it is important to investigate 
with a modality that can identify discrete pathology, like hysteroscopy or SIS.  
Moreover, a study looking at those with recurrent PMB after previous normal 
investigation showed a higher incidence of endometrial polyps suggesting these 
women should also be investigated with hysteroscopy or SIS [18].  Although 
outpatient hysteroscopy is more uncomfortable than TVUS, outpatient 
hysteroscopy is acceptable and very well tolerated [26]. Furthermore, there is 
evidence from structured interviews of patients that women are willing to 
undergo more invasive investigations, in the form of hysteroscopy, for the extra 
reassurance it provides [11]. 
 
Endometrial biopsy 
 
Outpatient endometrial biopsy is a blind procedure often undertaken with a 
pipelle device.  Although, such a biopsy is convenient, quick, safe and acceptable 
to most women, a large proportion of these biopsies may be reported as being 
insufficient or inadequate.  Furthermore, it has a lower sensitivity for picking up 
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focal and pedunculated lesions, such as a polyp or fibroid, which may be 
completely missed [27].  
 
Approach to management of menstrual disorders 
 
Management of menstrual disorders depends entirely on initial clinical 
evaluation, investigations and patient preference of treatment options. Both 
pharmacological and surgical approaches (minimally-invasive and open 
techniques) are suitable options. 
 
Pharmacological approach 
 
In most cases of AUB with anovulation pharmacological treatment is 
appropriate, while in cases of AUB due to structural causes, surgical intervention 
is indicated.  Some commonly prescribed medical treatments are listed below 
(Table 4). 
 
Pharmacological treatment options 
Oral contraceptive pills 
Gondatorophin-releasing hormone (GnRH) agonists 
levonorgestrel-releasing intrauterine system (LNG-IUS) 
Non-steroidal Anti-inflammatory Drugs (NSAIDs) 
Progesterone therapy 
Tranexamic acid  
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Desmopressin acetate (DDAVP in von Willebrand disease) 
 
Table 4: Pharmacological treatment options in menstrual disorders 
 
When considering treatment options individual patient factors such as age, body 
mass index, contraindications to therapy and treatment expectations should be 
kept in mind.  
 
Surgical approach  
 
Structural abnormalities require surgical treatment in most cases of AUB. These 
days most cases are managed using minimal-invasive techniques such as 
hysteroscopy and laparoscopy. Open-techniques such as laparotomy for 
myomectomy or hysterectomy are become less common and are used only in 
selected cases. 
 
Specific Role of hysteroscopy in evaluation of uterine cavity 
 
Office hysteroscopy is the main stay of modern day out patient management of 
AUB. It also remains a ‘gold standard’ tool for uterine cavity assessment and 
treatment of intra-uterine pathology such as polyps, submucous fibroids and 
endometrial pathology. It’s high sensitivity and specificity, safety and 
acceptability allows accurate diagnosis. Therefore, hysteroscopy is useful in 
diagnosis and treatment of menstrual disorders [28]. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Polyps 
 
Endometrial polyps arise from the endometrium and can present with 
asymptomatic women or in symptomatic women with post-coital or inter-
menstrual bleeding. 10% of women with infertility and between 25-60% of 
women with AUB may present with endometrial polyps [29,30].  A polyp is 
usually diagnosed using TVUS, SIS or at time of diagnostic hysteroscopy. The 
usual appearance of a polyp is that of a pedunculated fleshy pink lump or growth 
arising from the uterine endometrium with a narrow or broad stalk at the base. 
Most polyps are benign and have no consequence. However, some may be 
associated with endometrial hyperplasia with or without atypia and others with 
endometrial cancer. Therefore, hysteroscopic polypectomy is advised for 
symptom relief and to rule out malignancy, especially in the post-menopausal 
age group.  The traditional approach to polypectomy was blind avulsion, but this 
led to issues with recurrence of symptoms and missed histological diagnosis of 
endometrial cancer [31].  Increasingly, polypectomy is now done under direct 
vision in the outpatient setting without general anesthesia [8].  A recently 
completed large RCT comparing inpatient to outpatient polypectomy for 
abnormal uterine bleeding showed there was no difference in efficacy but a 
significant reduction in cost [32].  Further improvements in speed, acceptability, 
pain scores and failure rates have been made by using the new morcellator 
technologies [33]. 
  
 
Fibroids 
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Submucous fibroids can distort the uterine cavity and present as a pedunculated 
mass with symptoms of pain and heavy menstrual bleeding. They can also lead to 
infertility and recurrent miscarriage. Therefore, most cases warrant fibroid 
resection.  
The depth of invasion of the myometrium dictates the type and treatment 
options of the fibroids. Submucous fibroids are generally classified according to 
the European Society of Gynaecological Endoscopy (ESGE) into three types 
(Table 5).  Type 0 and 1 are suitable for hysteroscopic resection. Smaller fibroids 
may be resected in an outpatient setting. Fibroid resection in these cases is both 
curative and therapeutic. Moreover, fibroid resection improves fertility [34].  
Fibroids are easily identifiable on TVUS, but intramural fibroids may be wrongly 
diagnosed as submucosal and vice-versa.   This can have a significant impact on 
the management of women because the depth of myometrial invasion dictates 
the type of treatment available.  Outpatient diagnostic hysteroscopy can help 
with the grading of fibroids and the formulation of a management plan with the 
best technique, setting and preparation. Some small submucous fibroids may be 
amenable to resection in the outpatient setting.   
 
Type 0- whole of submucosal fibroid inside the uterine cavity.  
Type 1- <50% extension of submucous fibroid into myometrium. 
 Type 2- >50% extension into myometrium. 
 
Table 5: ESGE classification of Submucosal fibroids 
Endometrial pathology 
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Endometrial hyperplasia is the precursor for endometrial cancer. Endometrial 
cancer has innumerable appearances; with a combination of any of these 
features, i.e. thickened, irregular endometrium, friable cells with hemorrhagic 
appearances of the endometrial cavity.  
 
Although both cancerous and pre-cancerous endometrial disease can be 
identified by direct visualization, the ‘gold-standard’ for diagnosis is still 
histological sampling. However, hysteroscopy can be beneficial by allowing 
directed biopsies, as endometrial hyperplasia and cancer may be localized or 
global.  
A technique known as vaginoscopy which involves the insertion of a 
hysteroscope in to the uterine cavity without the use of a speculum or genital 
tract instrumentation can help histological sampling when access is limited, for 
example in cases of vaginal stenosis [35]. 
 
Intra-uterine adhesions 
 
Intrauterine adhesions, or Asherman’s syndrome, can present with amenorrhoea 
or irregular menstrual bleeding [26].   It is thought that scarring occurs when 
there is damage to the basilar layer of the endometrium.   Removal of adhesions 
is associated with resolution of bleeding symptoms and has been shown to 
increase clinical pregnancy rates in those with recurrent implantation failure 
following in vitro fertilization [36].  
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Traditionally, intrauterine adhesions were diagnosed with 
hysterosalpinography, but now hysteroscopy is the established technique 
diagnosing intrauterine adhesions [26]. The usual appearance of intrauterine 
adhesions is that of greyish-white fibrous bands (fine to dense) extending across 
the uterine cavity in a haphazard manner, which is frequently associated with 
obliteration of the uterine cavity.  Compared with radiological investigations 
hysteroscopy can more accurately confirm the presence, location and extent of 
scarring, although hysterosalphingography (HSG) is useful for determining tubal 
patency.   Hysteroscopy also has the advantage of being able to treat scar tissue 
with blunt, sharp or electrical dissection using miniature scissors and bipolar 
electrosurgical equipment that can be passed down the operating port of the 
hysteroscope.  
Filmy adhesions may be treated in the outpatient setting, but dense fibrous 
myometrial bands, which appear as pale patches, are normally removed with a 
general or regional anesthetic.  Outpatient hysteroscopy is also useful for a 
second look after treatment to ensure that scar tissue has not reformed.  
 
Summary 
 
Menstrual disorders presenting with abnormal uterine bleeding are a significant 
problem amongst both women of reproductive age and those who have 
undergone menopause. Hysteroscopy continues to have a well-recognized role in 
the diagnosis and management of abnormal uterine bleeding especially 
structural causes.  
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Practice points 
• A clear approach to clinical history and examination is often sufficient to 
indicate the underlying cause for AUB and the need for further testing. 
• Imaging should be undertaken where examination suggests a structural 
cause, where conservative management has failed or where there is a 
higher suggestive risk of malignancy. 
• Outpatient hysteroscopy is a quick, cost-effective and practical ‘See and 
treat’ approach to management of AUB. 
• SIS, TVUS and hysteroscopy all have comparable sensitivity and 
specificity for identification of uterine pathology. However, hysteroscopy 
remains the gold standard for uterine cavity assessment and treatment. 
• Newer techniques such as vaginoscopy in hysteroscopy are particularly 
useful in managing difficult cases such as vaginal stenosis where access to 
the uterine cavity is difficult. 
• Histological diagnosis remains the main stray of definitive diagnosis in 
cases of AUB. 
• Outpatient hysteroscopy is well accepted by patients and is the future of 
management of AUB in an outpatient setting.  
 
 
 
Research agenda 
• Further research is needed to decrease the pain and increase the 
acceptability of outpatient hysteroscopy.  
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• More research should be aimed at determining the cost-effectiveness and 
efficacy of different diagnostic strategies.   
 
 
Conflict of Interest: 
T. Justin Clark has received honoraria from Hologic, Gynecare, Smith & Nephew and 
Ethicon to run training workshops in office hysteroscopic techniques. Paul Smith has 
received honoraria from Smith and Nephew to present data in office hysteroscopic 
techniques.  Ayesha Mahmud did not report any potential conflicts of interest.  
 
 
References 
1  Pantaleoni D. On endoscopic examination of the cavity of the womb. Med Press 
Circ 1869;8:26–7. 
2  David J. De l’endoscopie de l’uterus ares avortement et dans es suites de 
couches a l’etat pathologique. Bull Soc Obstet 1907. 
3  Forestier M, Gladu A, Vulmiere J. Perfectionments de l’endoscope medicale. 
Presse Med 1943;5:46–7. 
4  Hopkins H. On the diffraction theory of optical images. Proc R Soc Lond 
1953;217:408–32. 
5  Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy 
versus day case hysteroscopy: randomised controlled trial. BMJ 2000;320:279–
82. 
6  Clark TJ, Bakour SH, Gupta JK, et al. Evaluation of outpatient hysteroscopy and 
ultrasonography in the diagnosis of endometrial disease. Obstet Gynecol 
2002;99:1001–7. 
7  Clark TJ, Gupta JK. Handbook of outpatient hysteroscopy: a complete guide to 
diagnosis and therapy. CRC Press 2005.  
8  Clark TJ, Cooper NA, Kremer C. Best practice in outpatient hysteroscopy.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9  Cooper NAM, Clark TJ. Cost-effectiveness of diagnostic strategies for the 
management of abnormal uterine bleeding (heavy menstrual bleeding and post-
menopausal bleeding): Systematic reviews, IPD meta-analysis and model based 
economic evaluation. http://www.hta.ac.uk/2145 (accessed 27 Sep2013). 
10  Moawad NS, Santamaria E, Johnson M, et al. Cost-effectiveness of office 
hysteroscopy for abnormal uterine bleeding. JSLS J Soc Laparoendosc Surg Soc 
Laparoendosc Surg 2014;18. doi:10.4293/JSLS.2014.00393 
11  Timmermans A, Opmeer BC, Veersema S, et al. Patients’ preferences in the 
evaluation of postmenopausal bleeding. BJOG Int J Obstet Gynaecol 
2007;114:1146–9. doi:10.1111/j.1471-0528.2007.01424.x 
12  Sweet MG, Schmidt-Dalton TA, Weiss PM, et al. Evaluation and management of 
abnormal uterine bleeding in premenopausal women. Am Fam Physician 
2012;85:35–43. 
13  CG44 N. Heavy Menstrual Bleeding. Clinical Guideline No. 44. National 
Collaborating Centre for Women’s and Children’s Health Commissioned by the 
National Institute for Health and Clinical Excellence. RCOG Press 2007.  
14  Munro MG, Critchley HOD, Fraser IS. The FIGO systems for nomenclature and 
classification of causes of abnormal uterine bleeding in the reproductive years: 
who needs them? Am J Obstet Gynecol 2012;207:259–65. 
doi:10.1016/j.ajog.2012.01.046 
15  Hatasaka H. The evaluation of abnormal uterine bleeding. Clin Obstet Gynecol 
2005;48:258–73. 
16  Bachmann LM, ter Riet G, Clark TJ, et al. Probability analysis for diagnosis of 
endometrial hyperplasia and cancer in postmenopausal bleeding: an approach 
for a rational diagnostic workup. Acta Obstet Gynecol Scand 2003;82:564–9. 
17  Breitkopf DM, Frederickson RA, Snyder RR. Detection of benign endometrial 
masses by endometrial stripe measurement in premenopausal women. Obstet 
Gynecol 2004;104:120–5. doi:10.1097/01.AOG.0000130065.49187.c8 
18  Smith PP, O’Connor S, Gupta J, et al. Recurrent postmenopausal bleeding: a 
prospective cohort study. J Minim Invasive Gynecol 2014;21:799–803. 
doi:10.1016/j.jmig.2014.03.007 
19  Gupta JK, Chien PFW, Voit D, et al. Ultrasonographic endometrial thickness for 
diagnosing endometrial pathology in women with postmenopausal bleeding: a 
meta-analysis. Acta Obstet Gynecol Scand 2002;81:799–816. 
20  Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to 
exclude endometrial cancer and other endometrial abnormalities. JAMA J Am 
Med Assoc 1998;280:1510–7. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21  Dimitraki M, Tsikouras P, Bouchlariotou S, et al. Clinical evaluation of women 
with PMB. Is it always necessary an endometrial biopsy to be performed? A 
review of the literature. Arch Gynecol Obstet 2011;283:261–6. 
doi:10.1007/s00404-010-1601-3 
22  Seshadri S, El-Toukhy T, Douiri A, et al. Diagnostic accuracy of saline infusion 
sonography in the evaluation of uterine cavity abnormalities prior to assisted 
reproductive techniques: a systematic review and meta-analyses. Hum Reprod 
Update Published Online First: 10 December 2014. 
doi:10.1093/humupd/dmu057 
23  Gkrozou F, Dimakopoulos G, Vrekoussis T, et al. Hysteroscopy in women with 
abnormal uterine bleeding: a meta-analysis on four major endometrial 
pathologies. Arch Gynecol Obstet Published Online First: 19 December 2014. 
doi:10.1007/s00404-014-3585-x 
24  NVOG (Dutch Society of Obsterics and Gynaecology). NVOG Guideline: Abnormal 
Vaginal Bleeding During the Postmenopause. 1997. 
25  Scottish Intercollegiate Guidelines Network. Investigation of postmenopausal 
bleeding 1st edn. 2002.www.sign.ac.uk 
26  Clark TJ. Outpatient hysteroscopy and ultrasonography in the management of 
endometrial disease. Curr Opin Obstet Gynecol 2004;16:305–11. 
27  Svirsky R, Smorgick N, Rozowski U, et al. Can we rely on blind endometrial biopsy 
for detection of focal intrauterine pathology? Am J Obstet Gynecol 
2008;199:115–e1 – 3. 
28  Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of 
endometrial cancer and hyperplasia: a systematic quantitative review. JAMA J 
Am Med Assoc 2002;288:1610–21. 
29  Bakour SH, Khan KS, Gupta JK. The risk of premalignant and malignant pathology 
in endometrial polyps. Acta Obstet Gynecol Scand 2002;81:182–3. 
30  Preutthipan S, Herabutya Y. Hysteroscopic polypectomy in 240 premenopausal 
and postmenopausal women. Fertil Steril 2005;83:705–9. 
doi:10.1016/j.fertnstert.2004.08.031 
31  Annan JJ, Aquilina J, Ball E. The management of endometrial polyps in the 21st 
century. Obstet Gynaecol 2012;14:33–8. doi:10.1111/j.1744-4667.2011.00091.x 
32  Cooper NAM, Clark TJ, Middleton L, et al. A randomised trial of outpatient versus 
inpatient uterine polyp treatment for abnormal uterine bleeding. BMJ 2015;In 
Print. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
33  Smith PP, Middleton LJ, Connor M, et al. Hysteroscopic morcellation compared 
with electrical resection of endometrial polyps: a randomized controlled trial. 
Obstet Gynecol 2014;123:745–51. doi:10.1097/AOG.0000000000000187 
34  Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic 
review of the evidence. Fertil Steril 2009;91:1215–23. 
doi:10.1016/j.fertnstert.2008.01.051 
35  Cooper NAM, Smith P, Khan KS, et al. Vaginoscopic approach to outpatient 
hysteroscopy: a systematic review of the effect on pain. BJOG Int J Obstet 
Gynaecol 2010;117:532–9. doi:10.1111/j.1471-0528.2010.02503.x 
36  Demirol A, Gurgan T. Effect of treatment of intrauterine pathologies with office 
hysteroscopy in patients with recurrent IVF failure. Reprod Biomed Online 
2004;8:590–4. 
 
Figures legend: 
Figure 1:  Menstrual disorders affecting women 
Figure 2: FIGO Classification of Abnormal uterine bleeding 
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Figure 1 
 
 
Figure 1:  Menstrual disorders affecting women 
•Amenorrhea (absence of mensuration for 3 or more cycles)
•Oligomenorrhea (Cycle longer than 35 days)
•Polymenorrhea ( Cycle shorter than 21 days)
•Dysmenorrhea (Excessive pain with mensuration)
•Intermenstrual bleeding (Bleeding between the menstrual cycles)
•Post-coital bleeding ( Bleeding after sexual intercourse)
•Heavy menstrual bleeding (Excessve bleeding more than 80ml during 
cycle affecting quality of life of the individual concerned)
Reproductive 
Years
•Post menopausal bleeding (Bleeding after 12months of Last menstrual 
period)
Post-
menopausal 
Years 
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Figure 2 
 
 
Structural Causes of AUB (PALM) Non-Structural causes of AUB 
(COEIN) 
Polyps (Endometrial or cervical) Coagulopathy 
Adenomysosis Ovulatory dysfunction 
Leiomyoma  Endometrial disorder (Primary) 
Malignancy and hyperplasia Iatrogenic 
 Not yet classified 
 
Figure 2: FIGO Classification of Abnormal uterine bleeding 
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Highlights 
 
• We examine the role of hysteroscopy in abnormal uterine bleeding. 
• Outpatient hysteroscopy is cheaper and safer than procedures performed 
under anaesthetic.   
• Both diagnosis and treatment can be implemented in one consultation 
(‘one-stop’ service). 
• There is rapid development of technology to increase feasibility of 
outpatient hysteroscopy. 
 
